Early Detection Program for Men at High Genetic Risk for Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This study aims to find prostate cancer early in men who have a genetic predisposition (inherited genetic mutations or strong family history) that puts them at higher risk. The goal is to detect it sooner, when treatment may be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 70 years old
- You have a genetic mutation known to increase prostate cancer risk (such as BRCA1/2, Lynch syndrome, p53, ATM, PALB2, or others) OR you are a blood relative of someone who carries one of these mutations
- You have a strong family history of breast, prostate, or ovarian cancer (at least 2 family members affected, or 1 diagnosed before age 50)
- You do not have a history of prostate cancer or prior prostate cancer treatment
- You are expected to live longer than 5 years and are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at prostate cancer screening for people who may be at higher risk because of a specific inherited (genetic) change. It may help your care team find the best screening approach to catch aggressive prostate cancer earlier.
This study tests a community health coach to help Black men with prostate cancer understand and access genetic testing that looks for inherited cancer risk. It may help you talk with your care team about testing and reduce barriers to getting results.
This study is for men who have a known inherited gene change that raises their prostate cancer risk. It aims to help prevent or detect prostate cancer earlier, and you may be asked to undergo MRI and other study steps.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.